PATENT CLAIM ANALYSIS

Application Number: 16162835
Application Type: Utility
Filing Date: 2018-10
Publication Date: 2019-06
Patent Classification: ["544", "360000"]

Abstract:
The invention relates to triazole compounds of formula I and I′ or pharmaceutically acceptable salts thereof, useful as modulators of demyelinating diseases: The invention also provides pharmaceutically acceptable compositions comprising the compounds of the invention, methods of using the compositions and kits thereof in the treatment of various demyelinating and neurodegenerative diseases, including multiple sclerosis.

Claim (Index 26):
The compound of any of  claim 20 , or a pharmaceutically acceptable salt thereof, wherein L 1  is a bond.

Metadata:
- Claim Count in Document: 2.0
- Percentile: 97.0
- Lexical Diversity: 1.53846
- Patent Class: 544.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15173177', '15037090', '15287922', '14509793', '11703522']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8067615363141543
- 35 USC 102 Novelty (BERT): 0.5904999480531902
- Combined Prediction Score: 0.7851353774880578
- Mean Citation Score: 421.580412
- Max Citation Score: 592.3917
- Similarity Product: 394.6508103360057

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 0
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test